Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

TRURAPI

SANOFI-AVENTIS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TRURAPI in Canada?

A shortage of TRURAPI 100UNIT is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 27, 2026), but it has not started yet.

When will TRURAPI be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Guide

Insulin Shortage in Canada: Current Status and What to Do

Whether insulin is in shortage in Canada right now, why insulin shortages get flagged faster than most, and what to do if your specific brand or formulation is affected.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file3 products
Affected strength100UNIT
Last updated2026-08-27

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NOVORAPID

NOVO NORDISK CANADA INC

100UNIT · DIN 02244353

Same strengthSame dosage formSame routeNo current shortage

KIRSTY

BIOCON BIOLOGICS CANADA INC

100UNIT · DIN 02520974

Same strengthSame dosage formSame routeNo current shortage

FIASP

NOVO NORDISK CANADA INC

100UNIT · DIN 02460408

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02506564

Strength

100UNIT

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

INSULIN ASPART

See all INSULIN ASPART products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History